A. Dov Goldstein's Insider Trades & SAST Disclosures
A. Dov Goldstein's most recent trade in Coya Therapeutics Inc was a trade of 5,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 25, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern A. Dov Goldstein.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coya Therapeutics Inc | Dov A. Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| BioAge Labs Inc. | Dov A. Goldstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 170,000 | 170,000 | - | - | Stock Option (Right to Buy) | |
| Coya Therapeutics Inc | Dov A. Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Gain Therapeutics Inc | Dov A. Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | A. Dov Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Gain Therapeutics Inc | Dov A. Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| Coya Therapeutics Inc | Dov A. Goldstein | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Common Stock, par value $0.0001 per share | |
| Coya Therapeutics Inc | Dov A. Goldstein | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2023 | 5,000 | 5,000 | - | - | Warrant to Purchase Common Stock | |
| Gain Therapeutics Inc | Dov A. Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 10,500 | 10,500 | - | - | Stock Option (right to buy) | |
| NeuBase Therapeutics Inc | Dov A. Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 37,600 | 37,600 | - | - | Stock option (right to buy) | |
| NeuBase Therapeutics Inc | Dov A. Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 38,135 | 38,135 | - | - | Stock option (right to buy) | |
| NeuBase Therapeutics Inc | Dov A. Goldstein | Director | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 18 Jun 2021 | 8,000 | 30,000 (0%) | 0% | 4.8 | 38,000 | Common Stock |
| NeuBase Therapeutics Inc | Dov A. Goldstein | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 26 Apr 2021 | 12,000 | 22,000 (0%) | 0% | 5 | 60,000 | Common Stock |
| NeuBase Therapeutics Inc | Dov A. Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2020 | 14,634 | 14,634 | - | - | Stock option (right to buy) | |
| NeuBase Therapeutics Inc | Dov A. Goldstein | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 30 Apr 2020 | 10,000 | 10,000 (0%) | 0% | 6 | 60,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges